At the gene expression level, fusion calling from RNA-sequencing data of six tumor samples again demonstrated Brd4::Nutm1 fusion with the designed junction as the only recurrent fusion (Fig S2E and F). This evidence concerns the gene NUTM1 and neoplasm.